Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;21(4):453-462.
doi: 10.1007/s10689-022-00291-3. Epub 2022 Mar 16.

Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review

Affiliations
Review

Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review

S H Beck et al. Fam Cancer. 2022 Oct.

Abstract

Germline biallelic pathogenic variants (PVs) in NTHL1 have since 2015 been associated with the autosomal recessive tumor predisposition syndrome: NTHL1 tumor syndrome or NTHL1-associated polyposis. In this systematic review, we aim to systematically investigate the phenotypic and genotypic spectrum of the condition including occurrence of both benign and malignant tumors. The databases PubMed, EMBASE, and Scopus were searched. The search was conducted the 25th of august 2021. We included patients with germline PVs, both heterozygous and homo-/compound heterozygous carriers. Twenty-one papers were selected including 47 patients with biallelic PVs in NTHL1 in 32 families. Twenty-three out of 47 patients (49%) were diagnosed with colorectal cancer (CRC) (mean age: 55, range: 31-73) and 12 out of 22 female patients (55%) were diagnosed with breast cancer (mean age: 49, range: 36-63). Apart from three, all patients who underwent a colonoscopy, had colonic adenomas (93%), and three patients (6%) had duodenal adenomatosis. We also identified 158 heterozygous carriers of germline PVs in NTHL1. Twenty-six out of 68 (38%) heterozygous carriers, who underwent colonoscopy, had colonic polyps or adenomas. Twenty-nine heterozygous carriers (18%) were diagnosed with CRC and 59 (49%) with breast cancer. We observed a high frequency of early onset CRC and breast cancer in patients with NTHL1 tumor syndrome. Subsequently, colorectal, breast, and endometrial cancer screening programs are recommended for NTHL1 biallelic carriers. Trial registry PROSPERO: CRD42021275159.

Keywords: Breast cancer; Colorectal cancer; Extraintestinal neoplasms; Intestinal neoplasms; NTHL1 tumor syndrome; NTHL1-associated polyposis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Weren RDA et al (2015) A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 47(6):668–671. https://doi.org/10.1038/ng.3287 - DOI - PubMed
    1. Weren RDA, Ligtenberg MJ, Geurts van Kessel A, de Voer RM, Hoogerbrugge N, Kuiper RP (2018) NTHL1 and MUTYH polyposis syndromes: two sides of the same coin? J Pathol 244(2):135–142. https://doi.org/10.1002/path.5002 - DOI - PubMed
    1. Kuiper RP, Nielsen M, de Voer RM, Hoogerbrugge N (1993) NTHL1 tumor syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) Seattle (WA)
    1. Altaraihi M, Gerdes AM, Wadt K (2019) A new family with a homozygous nonsense variant in NTHL1 further delineated the clinical phenotype of NTHL1-associated polyposis. Hum Genome Var 6(1):1–3. https://doi.org/10.1038/s41439-019-0077-3 - DOI
    1. Belhadj S et al (2017) Delineating the phenotypic spectrum of the NTHL1-associated polyposis. Clin Gastroenterol Hepatol 15(3):461–462. https://doi.org/10.1016/J.CGH.2016.09.153 - DOI - PubMed

Substances

LinkOut - more resources